237 related articles for article (PubMed ID: 23568281)
1. Switching to a low-fat diet attenuates the intensified doxorubicin cardiotoxicity associated with high-fat feeding.
Hydock DS; Lien CY; Jensen BT; Schneider CM; Hayward R
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1551-60. PubMed ID: 23568281
[TBL] [Abstract][Full Text] [Related]
2. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.
Hydock DS; Lien CY; Jensen BT; Parry TL; Schneider CM; Hayward R
Exp Biol Med (Maywood); 2012 Dec; 237(12):1483-92. PubMed ID: 23354407
[TBL] [Abstract][Full Text] [Related]
3. Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity.
Chicco AJ; Hydock DS; Schneider CM; Hayward R
J Appl Physiol (1985); 2006 Feb; 100(2):519-27. PubMed ID: 16210442
[TBL] [Abstract][Full Text] [Related]
4. Endurance exercise attenuates cardiotoxicity induced by androgen deprivation and doxorubicin.
Parry TL; Hydock DS; Jensen BT; Lien CY; Schneider CM; Hayward R
Can J Physiol Pharmacol; 2014 May; 92(5):356-62. PubMed ID: 24784469
[TBL] [Abstract][Full Text] [Related]
5. Exercise preconditioning provides long-term protection against early chronic doxorubicin cardiotoxicity.
Hydock DS; Lien CY; Jensen BT; Schneider CM; Hayward R
Integr Cancer Ther; 2011 Mar; 10(1):47-57. PubMed ID: 21382960
[TBL] [Abstract][Full Text] [Related]
6. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
[TBL] [Abstract][Full Text] [Related]
7. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
8. Acute exercise protects against doxorubicin cardiotoxicity.
Wonders KY; Hydock DS; Schneider CM; Hayward R
Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
Ammar el-SM; Said SA; Suddek GM; El-Damarawy SL
Can J Physiol Pharmacol; 2011 Apr; 89(4):269-76. PubMed ID: 21526973
[TBL] [Abstract][Full Text] [Related]
10. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.
Hydock DS; Lien CY; Schneider CM; Hayward R
Med Sci Sports Exerc; 2008 May; 40(5):808-17. PubMed ID: 18408619
[TBL] [Abstract][Full Text] [Related]
11. Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain.
Hydock DS; Wonders KY; Schneider CM; Hayward R
Anticancer Res; 2009 Nov; 29(11):4401-7. PubMed ID: 20032385
[TBL] [Abstract][Full Text] [Related]
12. Short-term exercise training attenuates acute doxorubicin cardiotoxicity.
Lien CY; Jensen BT; Hydock DS; Hayward R
J Physiol Biochem; 2015 Dec; 71(4):669-78. PubMed ID: 26403766
[TBL] [Abstract][Full Text] [Related]
13. Glutamine protects against doxorubicin-induced cardiotoxicity.
Cao Y; Kennedy R; Klimberg VS
J Surg Res; 1999 Jul; 85(1):178-82. PubMed ID: 10383856
[TBL] [Abstract][Full Text] [Related]
14. Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress.
Marques-Aleixo I; Santos-Alves E; Mariani D; Rizo-Roca D; Padrão AI; Rocha-Rodrigues S; Viscor G; Torrella JR; Ferreira R; Oliveira PJ; Magalhães J; Ascensão A
Mitochondrion; 2015 Jan; 20():22-33. PubMed ID: 25446396
[TBL] [Abstract][Full Text] [Related]
15. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
16. Time course of cardiomyopathy induced by doxorubicin in rats.
Medeiros-Lima DJM; Carvalho JJ; Tibirica E; Borges JP; Matsuura C
Pharmacol Rep; 2019 Aug; 71(4):583-590. PubMed ID: 31174019
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice.
Riad A; Bien S; Westermann D; Becher PM; Loya K; Landmesser U; Kroemer HK; Schultheiss HP; Tschöpe C
Cancer Res; 2009 Jan; 69(2):695-9. PubMed ID: 19147586
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: Emphasis on calcium homeostasis.
Awad HH; El-Derany MO; Mantawy EM; Michel HE; El-Naa MM; Salah El-Din RA; El-Brairy AI; El-Demerdash E
Biomed Pharmacother; 2021 Aug; 140():111679. PubMed ID: 34029952
[TBL] [Abstract][Full Text] [Related]
19. Fosinopril attenuates the doxorubicin-induced cardiomyopathy by restoring the function of sarcoplasmic reticulum.
Zhang YC; Tang Y; Zhang M; Chen J; Zhou Q; Sun YG; Chen MT; Xu WP
Cell Biochem Biophys; 2012 Dec; 64(3):205-11. PubMed ID: 22729889
[TBL] [Abstract][Full Text] [Related]
20. Effects of Resistance Exercise Training on Doxorubicin-Induced Cardiotoxicity.
Pfannenstiel K; Hayward R
J Cardiovasc Pharmacol; 2018 Jun; 71(6):332-339. PubMed ID: 29521673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
